Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and increased by 2.5 mg every 4 weeks up to a maintenance dose of 5-15 mg based on tolerability and therapeutic response
Production of GLP-1 The common factor for all three is a hormone called GLP-1 (glucagon-like peptide-1 to give it its full name, which hardly anyone ever does!), which helps control blood sugar levels and tells our brains when we're full
Kozicare Intimate Lightening Serum profoundly controls pigmentation and removes scars
Zhao M, Zhao L, Xiong X, He Y, Huang W, Liu Z, Ji L, Pan B, Guo X, Wang L, Cheng S, Xu M, Yang H, Yin Y, Garcia-Barrio MT, Chen YE, Meng X, Zheng L (2020) TMAVA, a metabolite of intestinal microbes, is increased in plasma from patients with liver steatosis, inhibits gamma-butyrobetaine hydroxylase, and exacerbates fatty liver in mice